NGT BioPharma Consultants’ Digital Innovation services are tailored to help biopharmaceutical companies develop digital products that transform R&D and manufacturing workflows, while also supporting business functions in developing and executing digital transformation strategies and adopting cutting-edge digital solutions.
Cloud based systems, highly connected labs (IOT), standardized and unified data models, product and process digital twins, and the use of artificial intelligence and machine learning offer significant opportunities to transform and accelerate R&D and manufacturing workflows. However, many functions are struggling to navigate these opportunities and move beyond lab digitization and automation.
For additional information pertaining to our Biopharmaceutical Digital Innovation service area, please contact Mark Buswell or Michael O’Brien via the contact information provided below. Alternatively, please fill out the New Inquiry form below and we will get back to you within 48 hours.